BEAM
Price
$21.66
Change
-$0.21 (-0.96%)
Updated
Nov 13 closing price
Capitalization
2.2B
109 days until earnings call
Intraday BUY SELL Signals
VCEL
Price
$39.84
Change
-$0.60 (-1.48%)
Updated
Nov 13 closing price
Capitalization
2.01B
104 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BEAM vs VCEL

Header iconBEAM vs VCEL Comparison
Open Charts BEAM vs VCELBanner chart's image
Beam Therapeutics
Price$21.66
Change-$0.21 (-0.96%)
Volume$3.65M
Capitalization2.2B
Vericel
Price$39.84
Change-$0.60 (-1.48%)
Volume$435.35K
Capitalization2.01B
BEAM vs VCEL Comparison Chart in %
View a ticker or compare two or three
VS
BEAM vs. VCEL commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and VCEL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (BEAM: $21.66 vs. VCEL: $39.84)
Brand notoriety: BEAM and VCEL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 145% vs. VCEL: 56%
Market capitalization -- BEAM: $2.2B vs. VCEL: $2.01B
BEAM [@Biotechnology] is valued at $2.2B. VCEL’s [@Biotechnology] market capitalization is $2.01B. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileVCEL’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • VCEL’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than VCEL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while VCEL’s TA Score has 6 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 7 bearish.
  • VCEL’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, VCEL is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а -6.44% price change this week, while VCEL (@Biotechnology) price change was +2.81% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.47%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +62.00%.

Reported Earning Dates

BEAM is expected to report earnings on Mar 03, 2026.

VCEL is expected to report earnings on Feb 26, 2026.

Industries' Descriptions

@Biotechnology (+1.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.2B) has a higher market cap than VCEL($2.02B). BEAM YTD gains are higher at: -12.661 vs. VCEL (-26.352). VCEL has higher annual earnings (EBITDA): 16.2M vs. BEAM (-414.33M). BEAM has more cash in the bank: 1.15B vs. VCEL (117M). VCEL has less debt than BEAM: VCEL (99.8M) vs BEAM (155M). VCEL has higher revenues than BEAM: VCEL (249M) vs BEAM (60.3M).
BEAMVCELBEAM / VCEL
Capitalization2.2B2.02B109%
EBITDA-414.33M16.2M-2,558%
Gain YTD-12.661-26.35248%
P/E RatioN/A153.23-
Revenue60.3M249M24%
Total Cash1.15B117M983%
Total Debt155M99.8M155%
FUNDAMENTALS RATINGS
VCEL: Fundamental Ratings
VCEL
OUTLOOK RATING
1..100
25
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
PROFIT vs RISK RATING
1..100
72
SMR RATING
1..100
87
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMVCEL
RSI
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 3 days ago
83%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 3 days ago
83%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 3 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 3 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 3 days ago
76%
Advances
ODDS (%)
Bullish Trend 9 days ago
78%
Bullish Trend 4 days ago
78%
Declines
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 23 days ago
73%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 3 days ago
80%
Aroon
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 3 days ago
71%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signal:
Gain/Loss:
VCEL
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ARDEX6.15-0.03
-0.49%
AMG River Road Dividend All Cap Value N
VGWAX35.10-0.19
-0.54%
Vanguard Global Wellington Admiral
MALOX20.79-0.22
-1.05%
BlackRock Global Allocation Instl
ECTMX17.20-0.23
-1.32%
Eaton Vance Dividend Builder C
IBSAX13.39-0.24
-1.76%
VY® Baron Growth A

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
-0.96%
CRSP - BEAM
70%
Closely correlated
-2.07%
RXRX - BEAM
62%
Loosely correlated
-6.88%
NTLA - BEAM
61%
Loosely correlated
-8.64%
PRME - BEAM
61%
Loosely correlated
-6.20%
AXON - BEAM
57%
Loosely correlated
-2.15%
More

VCEL and

Correlation & Price change

A.I.dvisor indicates that over the last year, VCEL has been loosely correlated with VCYT. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if VCEL jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VCEL
1D Price
Change %
VCEL100%
-1.49%
VCYT - VCEL
52%
Loosely correlated
-0.84%
TECH - VCEL
42%
Loosely correlated
+3.75%
BEAM - VCEL
39%
Loosely correlated
-2.71%
FTRE - VCEL
39%
Loosely correlated
-3.82%
AXON - VCEL
38%
Loosely correlated
-0.47%
More